Clinical Trial Update: Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating toripalimab with platinum plus etoposide in extensive-stage small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED